Effect of 6(5H)-phenanthridinone, an inhibitor of poly(ADP-ribose) polymerase, on cultured tumor cells.

Abstract

By catalyzing posttranslational modifications of nuclear proteins, poly(ADP-ribose) polymerase (PARP) controls their functions and therefore constitutes an enzyme of crucial importance in tumor development. In this study, we have investigated the action of 6(5H)-phenanthridinone, an isoquinoline derivative and one of the most potent PARP inhibitors described so far, on RDM4 murine lymphoma cells in culture. We also examined whether this compound could act synergistically with an antineoplastic drug in tumor-cell destruction. Our results demonstrate that a marked inhibition of PARP activity can be obtained in whole cells after a short incubation, and that this compound, when associated with an alkylating agent, dichloro-2,2' N-methyldiethylamine (chloromethine), leads to a marked drop in the RDM4 proliferation, indicative of a synergy between the two compounds.

• Authors: D Weltin, J Marchal, P Dufour, E Potworowski, D Oth, P Bischoff
• Journal: Oncology research (Oncol Res) Vol. 6 Issue 9 Pg. 399-403 ( 1994) ISSN: 0965-0407 [Print] United States
• PMID: 7703525 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antineoplastic Agents
• Phenanthrenes
• Poly(ADP-ribose) Polymerase Inhibitors
• Mechlorethamine
• phenanthridone

Topics

• Animals
• Antineoplastic Agents (administration & dosage, pharmacology)
• Antineoplastic Combined Chemotherapy Protocols (pharmacology)
• Cell Division (drug effects)
• Cell Survival (drug effects)
• Drug Screening Assays, Antitumor
• Drug Synergism
• Lymphoma (drug therapy, enzymology, pathology)
• Mechlorethamine (administration & dosage)
• Mice
• Phenanthrenes (administration & dosage, pharmacology)
• Poly(ADP-ribose) Polymerase Inhibitors
• Tumor Cells, Cultured (drug effects)